/Unitedhealth%20Group%20Inc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
UnitedHealth Group (UNH), the nation's largest private health insurer, has had a challenging 2025. Shares are down 29% year to date (YTD), wiping out years of steady gains and eroding investor confidence in a company long seen as nearly impenetrable in terms of scale and execution. The stock has even dipped 43% from its 52-week high of $630.73.
Yet, beneath the current turbulence sits a company with unmatched reach, diversified business lines, and a renewed focus on operational discipline. UnitedHealth has faced crises before and rebounded. The key question for investors is whether today’s valuation reset presents a rare buying opportunity to buy this blue-chip stock. Let’s find out.
